Emergent BioSolutions, Inc. (EBS)

5.66 +0.48 (+9.27%) USD  |  NYSE  |  Aug 25, 15:23
More

Emergent BioSolutions EPS Estimates for Next Quarter

EPS Estimates for Next Quarter Chart

View EPS Estimates for Next Quarter for EBS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Quarter Chart
Start Trial

Historical EPS Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 21, 2026 --
August 06, 2026 --
June 01, 2026 --
May 04, 2026 --
February 27, 2026 --
August 07, 2025 --
July 25, 2025 --
May 08, 2025 --
April 30, 2025 --
Date Value
March 04, 2025 --
December 23, 2024 --
September 26, 2024 --
September 25, 2024 --
August 29, 2024 --
August 09, 2024 --
June 20, 2024 --
May 01, 2024 --
April 11, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Quarter Range, Past 5 Years

View EPS Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Quarter Benchmarks

View EPS Estimates for Next Quarter Benchmarks
Start Trial
Exelixis, Inc. Upgrade
Capricor Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Akebia Therapeutics, Inc. Upgrade
Arcutis Biotherapeutics, Inc. Upgrade

EPS Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade